Investment Approach
Conviction built on evidence.
We invest in differentiated, defensible science with meaningful clinical and commercial potential — from Series A through growth, with selective later-stage opportunities, across global life sciences and healthcare.
Differentiated
Science with a clear mechanism, a defensible position and a reason to exist that incumbents cannot easily replicate.
Evidenced
A defined path to human data, a credible regulatory pathway and named strategic partners who validate the opportunity.
Commercial
A real market, a plausible route to reimbursement or revenue, and a place where our networks can accelerate growth.
We underwrite the science first — every thesis is stress-tested against mechanism, data and regulatory reality before capital is committed.
Nine gates between a first meeting and a decision.
01
Strategic Screening
Alignment with mandate and portfolio construction.
Every investment carries a completed written memorandum and named conditions to closing, reviewed with specialists from our advisory network before it reaches the Investment Committee.
From discovery to the world.
- 01
Identify exceptional science
- 02
Underwrite with discipline
- 03
Invest with conviction
- 04
Accelerate commercialisation
- 05
Build long-term value